Immune cell alterations in blood tied to Parkinson’s neurodegeneration
A higher neutrophil-to-lymphocyte ratio and low lymphocyte counts in the bloodstream, thought to reflect greater systemic inflammation, were associated with…
Articles by Lindsey Shapiro, PhD
Degree of DAT protein loss in brain may mark Parkinson’s severity
The greater the loss of dopamine transporter (DAT) protein in a brain region significantly affected by Parkinson’s disease —…
Dipraglurant eases motor, nonmotor symptoms in rodents
Dipraglurant, an investigational oral therapy from Addex Therapeutics, eased motor and nonmotor symptoms associated with Parkinson’s disease in…
Small molecules quell toxic alpha-synuclein in preclinical studies
Wren Therapeutics has developed oral small molecules that suppress the production of toxic alpha-synuclein protein forms in cellular and…
Ovary removal surgery before age 43 may increase the risk of Parkinson’s
Women who undergo surgery to remove both of their ovaries before age 43 have a five times higher risk of…
A dose of ‘hopamine’ may help personalize Parkinson’s care
While dopamine-replacing therapies are a key component of Parkinson’s disease care, they only reflect a person’s physical characteristics or…
BlueRock to apply digital health technologies in observational study
BlueRock Therapeutics will use digital health technologies from Rune Labs and Emerald Innovations to remotely monitor a subset of…
Parkinson’s Expo returns with free educational program on March 25
The sixth annual Parkinson’s Expo, a free and educational conference covering a range of topics related to Parkinson’s disease,…
Parkinson’s Foundation wins nearly $800K for research, genetic testing
The Parkinson’s Foundation was awarded nearly $800,000 to support research efforts that aim to improve the lives of the…
Patients with persistent tremor sought for suvecaltamide trial
Parkinson’s disease patients with inadequately controlled tremors are being sought for a Phase 2 clinical trial of suvecaltamide, an oral…